David, I don't know if you seen this when I posted it on 12/13/12, but here is a report made last year by Memorial Sloan Kettering Cancer Center in NYC, to the Journal of Clinical Oncology, questioning wether
Erbitux should replace Cisplatin for chemoradiation in Locally Advanced Head and Neck Cancer, outside clinical trials, anytime soon, until further studies are done.
The study also said the combination of Cisplatin and
Erbitux had dissapointing results.
http://jco.ascopubs.org/content/early/2012/11/30/JCO.2012.46.9049